A PYMNTS Company

PBMs: The Middlemen Who Drive up Drug Costs

BY | May 31, 2022

Ensuring effective competition in healthcare markets is a critical priority for antitrust enforcers.  Traditionally enforcement has focused on manufacturers and providers but far too little attention has been given to…

Ensuring effective competition in healthcare markets is a critical priority for antitrust enforcers.  Traditionally enforcement has focused on manufacturers and providers but far too little attention has been given to intermediaries such as Pharmacy Benefit Managers (“PBMs”).  A lack of attention and enforcement has permitted a highly concentrated PBM market to evolve in which PBMs prevent transparency and exploit conflicts of interest to raise costs and deny necessary low-cos

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 44.213.60.33

Please verify email or join us to access premium content!